SBLOF'
s Days Payable Range Over the Past 10 Years
Min: 2.33 Med: 4.64 Max: 13.2
Current: 12.38
During the past 13 years, Shin Nippon Biomedical Laboratories's highest Days Payable was 13.20. The lowest was 2.33. And the median was 4.64.
SBLOF's Days Payable is ranked worse than 93.68% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.275
vs SBLOF: 12.38
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shin Nippon Biomedical Laboratories Days Payable Chart
For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shin Nippon Biomedical Laboratories Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where Shin Nippon Biomedical Laboratories's Days Payable falls into.
Shin Nippon Biomedical Laboratories Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shin Nippon Biomedical Laboratories (SBLOF) has a Days Payable of 8.97 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shin Nippon Biomedical Laboratories and its competitors. This is 93% above median its historical median of 4.64. Over the past decade, Shin Nippon Biomedical Laboratories' Days Payable has ranged from 2.33 to 13.20. According to the industry distribution chart, Shin Nippon Biomedical Laboratories ranks #178 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 93.7%.
Is Shin Nippon Biomedical Laboratories' Days Payable too high?
Shin Nippon Biomedical Laboratories' current Days Payable of 8.97 is 93% above median its 10-year median of 4.64. Over the past 10 years, this metric has ranged from a low of 2.33 to a high of 13.20. The Medical Diagnostics & Research industry median Days Payable is 67.28. Shin Nippon Biomedical Laboratories' value of 8.97 is 86.7% below this industry median. Based on the distribution chart, Shin Nippon Biomedical Laboratories ranks #178 out of 190 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shin Nippon Biomedical Laboratories ranks #178 out of 190 companies for Days Payable. This places Shin Nippon Biomedical Laboratories in the lower half of its industry. The industry median Days Payable is 67.28. Shin Nippon Biomedical Laboratories' value of 8.97 is 86.7% below this benchmark. Historically, Shin Nippon Biomedical Laboratories' own Days Payable has ranged from 2.33 to 13.20 over the past decade. While the company's 10-year median is 4.64 vs. the industry median of 67.28, Shin Nippon Biomedical Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 67.28, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shin Nippon Biomedical Laboratories's current Days Payable of 8.97 is 86.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shin Nippon Biomedical Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shin Nippon Biomedical Laboratories's current Days Payable is 8.97, which is 93% above median its own 10-year median of 4.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current Days Payable of 8.97. The stock's GF Value™ is $14.46, compared to a current price of $9.16 — trading 36.6% below its estimated fair value. The current Days Payable is 8.97, which is 93% above median its 10-year median of 4.64 and 86.7% below the Medical Diagnostics & Research industry median of 67.28. Shin Nippon Biomedical Laboratories' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current Days Payable is 8.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?
Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued.
The current stock price of $9.16 is trading 36.6% below its estimated GF Value™ of $14.46.
Key valuation signals for SBLOF:
Days Payable: 8.97 (93% above median its 10-year median of 4.64)
GF Value™: $14.46 vs. price of $9.16 (36.6% below fair value)
Industry Position: 86.7% below the Medical Diagnostics & Research median (#178 of 190)
No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shin Nippon Biomedical Laboratories Business Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
77GF Score
Get the complete analysis for SBLOF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBLOF has been successfully added to your 
